XML 37 R27.htm IDEA: XBRL DOCUMENT
v3.21.1

Business Combinations (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2021
Business Combinations [Abstract] |
Schedule of recognized identified assets acquired and liabilities assumed | The following table summarizes the acquisition-date fair value of consideration transferred and the identifiable assets purchased and liabilities assumed as part of our acquisition of Able Health (in thousands):
Assets acquired: |
Accounts receivable | $ | 633 |
Prepaid expenses and other assets | 57 |
Developed technologies | 7,500 |
Customer relationships | 600 |
Trademarks | 100 |
Total assets acquired | 8,890 |
Less liabilities assumed: |
Accounts payable and other current liabilities | 91 |
Deferred revenue | 762 |
Net deferred tax liabilities | 1,280 |
Total liabilities assumed | 2,133 |
Total assets acquired, net | 6,757 |
Goodwill | 14,725 |
Total consideration transferred, net of cash acquired | $ | 21,482 |
The following table summarizes the acquisition-date fair value of consideration transferred and the identifiable assets purchased and liabilities assumed as part of our acquisition of Healthfinch (in thousands):
Assets acquired: |
Accounts receivable | $ | 1,408 |
Prepaid expenses and other assets | 347 |
Developed technologies | 8,100 |
Customer relationships and contract backlog | 10,000 |
Trademarks | 200 |
Total assets acquired | 20,055 |
Less liabilities assumed: |
Accounts payable and other current liabilities | 408 |
Deferred revenue | 2,100 |
Total liabilities assumed | 2,508 |
Total assets acquired, net | 17,547 |
Goodwill | 32,960 |
Total consideration transferred, net of cash acquired | $ | 50,507 |
The following table summarizes the acquisition-date fair value of consideration transferred and the identifiable assets purchased and liabilities assumed as part of our acquisition of Vitalware (in thousands):
Assets acquired: |
Accounts receivable | $ | 3,220 |
Prepaid expenses and other assets | 469 |
Developed technologies | 18,000 |
Customer relationships and contract backlog | 43,000 |
Trademarks | 1,400 |
Total assets acquired | 66,089 |
Less liabilities assumed: |
Accounts payable and other current liabilities | 766 |
Deferred revenue | 2,589 |
Total liabilities assumed | 3,355 |
Total assets acquired, net | 62,734 |
Goodwill | 56,443 |
Total consideration transferred, net of cash acquired | $ | 119,177 |
Pro Forma Summary | The following table reflects our unaudited pro forma combined results of operations for the years ended December 31, 2020 and 2019 as if the acquisitions of Able Health, Healthfinch, and Vitalware had taken place on January 1, 2019:
| Year Ended December 31,
| 2020 |  | 2019
| (unaudited)
Total pro forma revenues | $ | 209,409 |  |  | $ | 173,973 |
Pro forma net loss | (124,485) |  |  | (90,850) |

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(3) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration